PCM
Peregrine Capital Management Portfolio holdings
AUM
$3.32B
This Quarter Return
-2.76%
1 Year Return
+23.17%
3 Year Return
+97.35%
5 Year Return
+164.6%
10 Year Return
–
AUM
$3.35B
AUM Growth
+$3.35B
(-8.9%)
Cap. Flow
-$148M
Cap. Flow
% of AUM
-4.41%
Top 10 Holdings %
Top 10 Hldgs %
19.84%
Holding
330
New
10
Increased
55
Reduced
221
Closed
12
Top Buys
| 1 |
DraftKings
DKNG
|
$27.5M |
| 2 |
Flywire
FLYW
|
$10.8M |
| 3 |
Western Alliance Bancorporation
WAL
|
$9.94M |
| 4 |
Pinnacle Financial Partners
PNFP
|
$9.86M |
| 5 |
PENN Entertainment
PENN
|
$9.49M |
Top Sells
| 1 |
MarketAxess Holdings
MKTX
|
$20.4M |
| 2 |
Etsy
ETSY
|
$16.7M |
| 3 |
Unity
U
|
$16.5M |
| 4 |
BKI
Black Knight, Inc. Common Stock
BKI
|
$13.8M |
| 5 |
LGF.B
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
|
$11.8M |
Sector Composition
| 1 | Technology | 23.4% |
| 2 | Healthcare | 16.46% |
| 3 | Financials | 15.05% |
| 4 | Consumer Discretionary | 12.82% |
| 5 | Industrials | 12.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Sarepta Therapeutics
SRPT
$1.98B
| $5.48M | 0.16% |
45,178
+5,166
| +13% | +$626K |
|
227
Coherus Oncology, Inc. Common Stock
CHRS
$144M
| $5.16M | 0.15% |
1,378,567
-58,986
| -4% | -$221K |
|
|
SILK
228
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $5.12M | 0.15% |
341,839
-21,235
| -6% | -$318K |
|
229
Tandem Diabetes Care
TNDM
$837M
| $5.05M | 0.15% |
243,355
+52,897
| +28% | +$1.1M |
|
230
RB Global
RBA
$21.3B
| $5.01M | 0.15% |
80,160
-5,237
| -6% | -$327K |
|
231
Synaptics
SYNA
$2.61B
| $4.99M | 0.15% |
55,801
-3,507
| -6% | -$314K |
|
232
Ultragenyx Pharmaceutical
RARE
$3.05B
| $4.99M | 0.15% |
139,870
-8,774
| -6% | -$313K |
|
233
Akero Therapeutics
AKRO
$3.61B
| $4.83M | 0.14% |
+95,447
| New | +$4.83M |
|
234
BioLife Solutions
BLFS
$1.19B
| $4.75M | 0.14% |
344,150
-21,611
| -6% | -$298K |
|
235
Transmedics
TMDX
$3.65B
| $4.7M | 0.14% |
85,800
-24,587
| -22% | -$1.35M |
|
236
Myriad Genetics
MYGN
$620M
| $4.5M | 0.13% |
280,767
-17,622
| -6% | -$283K |
|
237
Frontier Group Holdings
ULCC
$1.28B
| $3.92M | 0.12% |
809,340
-34,736
| -4% | -$168K |
|
|
LGF.B
238
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $3.92M | 0.12% |
497,467
-1,495,057
| -75% | -$11.8M |
|
|
SWTX
239
DELISTED
SpringWorks Therapeutics
SWTX
| $3.69M | 0.11% |
159,478
-10,015
| -6% | -$232K |
|
|
CDMO
240
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $3.63M | 0.11% |
384,608
-23,478
| -6% | -$222K |
|
241
Ventyx Biosciences
VTYX
$182M
| $3.28M | 0.1% |
94,565
-5,920
| -6% | -$206K |
|
242
Syndax Pharmaceuticals
SNDX
$1.37B
| $3.19M | 0.1% |
219,974
-13,764
| -6% | -$200K |
|
|
STKL
243
SunOpta
STKL
$734M
| $3.17M | 0.09% |
940,535
+709,158
| +306% | +$2.39M |
|
244
Digital Turbine
APPS
$453M
| $3.09M | 0.09% |
510,916
-21,903
| -4% | -$133K |
|
|
LUCK
245
Lucky Strike Entertainment Corporation
LUCK
$1.46B
| $3.06M | 0.09% |
318,245
-19,920
| -6% | -$192K |
|
246
Monro
MNRO
$505M
| $3.03M | 0.09% |
108,938
-6,855
| -6% | -$190K |
|
247
Adaptive Biotechnologies
ADPT
$1.95B
| $2.4M | 0.07% |
439,955
-27,331
| -6% | -$149K |
|
248
OceanFirst Financial
OCFC
$1.04B
| $2.14M | 0.06% |
147,748
-328,910
| -69% | -$4.76M |
|
249
Manhattan Associates
MANH
$12.6B
| $1.94M | 0.06% |
9,810
-404
| -4% | -$79.9K |
|
250
Bunge Global
BG
$16.3B
| $1.48M | 0.04% |
13,659
-555
| -4% | -$60.1K |
|